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Cellular heterogeneity between brain regions has been attributed to differences in neurons, 
although differences between astrocytic glia of distinct brain regions are emerging.  
Relatively little is understood concerning heterogeneity in astrocyte structural dynamics 
between brain regions.  The following studies report differences in structural 
complexities and diurnal morphological dynamics between astrocytes of the hippocampal 
dentate gyrus (DG) and suprachiasmatic nucleus (SCN).  Glial fibrillary acidic protein 
(GFAP) branch terminal-points are significantly less numerous in the DG than the SCN.  
Terminal-points increase and decrease in complexity throughout the day-night cycle.  
Branching peaks at early night in the DG, but at early day in the SCN.  Daily changes in 
cytoskeleton architecture in the DG and SCN are mediated by protein reorganization and 
not turnover.  Light is necessary for astrocyte rhythms, as both brain regions do not 
exhibit morphology changes in constant darkness.  Light exposure at early night rapidly 
alters astrocyte branch complexity in both the DG and SCN, but in opposite ways.  The 
effect of light on astrocyte complexity in the SCN, but not DG, is mediated by 
glutamatergic signaling.  Astrocyte remodeling in the SCN upon dehydration is similar to 
effects in the supraoptic nucleus (SON), but no dehydration changes are seen in the DG.  
These findings extend recent observations of astrocyte heterogeneity with evidence for 
daily, region-specific structural remodeling.  They also provide evidence for a role of 
light signaling in modulating astrocyte structure.  The relative timing of high-low 
astrocyte complexity suggests that daily changes in astrocyte morphology in the DG and 
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CHAPTER 1.  ASTROCYTE FUNCTION, PLASTICITY, AND FILAMENTS 
  
 Glia of the mammalian central nervous system (CNS) have long been understood 
to be the support system of the brain, providing nutrients and modulating transmission at 
the synapse.1-3  CNS glial subtypes include astrocytes, oligodendrocytes, radial glia, 
oligodendrocyte precursors, ependymal cells, synantocytes, and tanycytes, and these cells 
serve a variety of vital brain functions (Table 1).  Astrocytes and oligodendrocytes 
predominate in the cortex relative to other glial subtypes,4,5 and astrocytes are well 
known for modulating synaptic transmission through glutamate uptake,6,7 whereas 
oligodendrocytes provide myelin for CNS neurons.8,9  Astrocytes also participate in ion 
regulation, synapse formation, glycogen metabolism and blood flow regulation.10,3,11-13  
Astrocytes in the CNS may be glial fibrillary acidic protein (GFAP)-positive or GFAP-
negative, recognized by the expression of glutamine synthetase instead.14  The described 
work focuses on GFAP-positive astrocytes in particular.   
Expression of proteins such as ion channels, enzymes and neuropeptides has been 
used to distinguish astrocytes from different brain regions.15-21  A great degree of 
divergence between separate populations of astrocytes exists within the central nervous 
system, and morphology is only one of these region-specific characteristics.  In regions 
including the cortex, amygdala and brainstem, morphological markers such as 
cytoskeletal GFAP, cytosolic calcium-binding protein S100ß, and green fluorescent 
protein (GFP) have been used to observe regional heterogeneity of astrocyte structure.22  
No quantitative parameters have been defined to distinguish these morphologies. 
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Astrocytes in the Hippocampus 
 The hippocampus has been a focus for the study of CNS astrocytes, and a number 
of studies in the hippocampus have shed much light on the functions of astrocytes overall.  
While heterogeneity of astrocytes from different brain regions is established,22 distinct 
subregions of astrocytes exist within the hippocampus.  Indeed, one of the most 
provocative studies examining astrocyte heterogeneity determined that subtypes within 
the CA1 region of the hippocampus can be differentiated by the expression of either 
glutamate (Glu) transporters or Glu receptors; no identified astrocyte in the area 
expresses both of these membrane proteins.23  The dentate gyrus (DG) is a favored area 
for study of astrocyte morphology.24-27  It is also one of two hippocampal regions to show 
diurnal variation in mRNA of brain-derived neurotrophic factor (BDNF,)28 a key 
mediator of learning and memory in the hippocampus,29 and expression of the TrkB 
receptor,30 the downstream target of BDNF.31  Daily astrocyte structural changes, 
however, have not been observed in the DG.  
 A role of neuron-astrocyte communication during astrocyte development was 
established in the hippocampus, using cell cultures from transgenic mouse hippocampi.32   
Blocking neuronal electrical signaling with tetrodotoxin (TTX) in mixed early postnatal 
hippocampal cultures inhibits astrocyte development, and purinergic signaling blockers 
further reduces the growth of developing astrocytes.  Roles of atrocytes in the physiology 
of the adult hippocampus have been elucidated as well, ranging from regulation of 
extracellular ion concentrations to assisting in synaptic depression associated with 
learning.33,34  An astrocyte-specific potassium channel, Kir4.1, has been shown to be 
particularly important in a number of hippocampal activities, including uptake of Glu 
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from hippocampal synapses, spontaneous neuronal firing, and modulation of synaptic 
strength.10  Additionally, hippocampal astrocytes initiate neuronal activity through 
propagation of calcium currents, a response potentially mediated by Glu.35  
 Astrocytic functions in the hippocampus support neuronal plasticity, including 
long-term potentiation (LTP), a phenomenon associated with learning and memory.6,34-38  
D-serine is an astrocyte-enriched molecule36 that contributes fundamentally to LTP in the 
hippocampus.  Dispersed hippocampal neurons experience enhanced LTP with D-serine 
supplementation, and cultured neurons as well as hippocampal slices undergo LTP 
suppression in the presence of a D-serine-degrading enzyme.37  A complete LTP 
blockade through clamping of astrocytic intracellular calcium in hippocampal slices is 
reversed through D-serine supplementation, and depletion of D-serine prevents LTP in 
this tissue.38  These findings demonstrate that hippocampal LTP requires the presence of 
D-serine from astrocytes.  
 Astrocytes in the hippocampus are not only the modulators but also the recipients 
of synaptic transmission.39  A subpopulation of astrocytes within the hippocampus, 
termed GluR cells, receive presynaptic inputs from hippocampal neurons and exhibit 
membrane potential changes as well as excitatory postsynaptic currents (ePSCs).  These 
astrocytes, which differ from other hippocampal astrocytes in their expression of Glu 
receptors and not transporters, also distinguish themselves by their lack of gap junction 
coupling with other astrocytes.40  Whether similar transporter and gap junction 
distinctions exist in astrocytes of other brain regions is unclear. 
Intriguingly, astrocytes in the hippocampus may play a role in psychiatric disease.  
Rodents subjected to chronic psychosocial stress possess decreased number and size of 
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hippocampal astrocytes compared to controls.41  This finding echoes the hippocampal 
volume reduction noted in patients with diagnosed depressive disorders.42,43  
Hippocampal astrocytes display a wide range of attributes that distinguish them from 
other regional astrocytes and possess physiological roles that are likely characteristic of 
astrocytes throughout the brain.  
Astrocytes in the Suprachiasmatic Nucleus 
The suprachiasmatic nucleus (SCN) of the mammalian brain is the central 
circadian clock of the mammalian organ system,44-46 coordinating time of day information 
to the rest of the body.  Peripheral clocks are responsible for keeping time in their 
respective regions,47 but the SCN keeps “central” time and communicates this rhythm to 
coupled oscillators.48  The SCN is comprised of both neurons and astrocytes.  In the 
rodent SCN, neurons in the SCN are reported to be more numerous than astrocytes by a 
factor of 3, determined using comparative surface area and volume measurements in 
electron micrograph and light microscopy images.49   More recently, a 1:1 ratio of 
neurons to non-neuronal cells was proposed for the human brain, determined using 
modern cell fractionation techniques.50 
 Early studies of SCN astrocyte physiology suggest a role for calcium in the 
relationship between SCN neurons and astrocytes.51  Transient but consistent calcium 
oscillations exist in dispersed SCN astrocytes whereas dispersed SCN neurons display 
irregular calcium profiles.  Astrocytes, then, may transmit calcium through the SCN via 
extensive gap junction connections.  Treating a hypothalamic brain slice with chemicals 
that disrupt intact gap junctions between astrocytes of the SCN delays the phasing of 
neuronal firing rates of the brain slice.52  SCN astrocytes are furthermore frequently 
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juxtaposed with neurons expressing vasointestinal peptide (VIP) as well as those 
expressing arginine vasopressin (AVP), implicating astrocytes in modulating these 
neurons.53   
The exact functions of SCN astrocytes remains unclear, but a relationship exists 
between SCN astrocytes and the transmission of light information from the retina to the 
SCN.  SCN astrocytes cluster in the ventrolateral SCN,54	  where retinal ganglion cell 
terminals from the eye also preferentially localize.55,56	   GFAP is a CNS astrocyte-
enriched intermediate filament that is used as a marker for the astrocyte cytoskeleton.  
Enucleated rats possess minimized GFAP distribution in the SCN.57  Rats that are raised 
in constant light display similarly reduced GFAP distribution throughout the SCN.58,59  
These findings show retinal input-mediated regulation of SCN astrocytes.  A more direct 
involvement of SCN astrocytes in generating circadian rhythms is supported by 
transforming growth factor (TGF)-α localization in SCN astrocytes, as TGF-α has a 
possible role in maintaining circadian locomotor activity.60   
 If astrocytes play a functional role in circadian rhythms, expression of GFAP may 
fluctuate over the course of a day.  Several studies have attempted to address this 
question using immunohistochemistry either qualitatively or semi-quantitatively.  In one 
immunohistochemical study, SCN GFAP expression does not qualitatively fluctuate over 
the day, although under constant light conditions, GFAP immunoreactivity patterns differ 
from those of mice raised under light:dark cycles.58  Contrary to these results, a separate 
study shows that GFAP not only fluctuates over the course of day, but peak-trough times 
vary seasonally.61  Without addressing seasonality, an additional study finds that GFAP 
immunohistochemistry labeling is consistently highest at night and lowest during the 
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day.62  However, quantification of actual protein levels by Western blot analysis has not 
been examined. 
 The structural organization of astrocytes within the SCN, irrespective of GFAP 
expression, has also been studied diurnally.  A non-quantitative observational study of 
astrocyte architecture related that GFAP in the hamster SCN has an isolated, restricted 
distribution at early night, whereas at late day, the cells appear to form a dispersed 
network of cytoskeletal filaments.63  This study describes astrocyte cytoskeleton 
morphology in particular rather than GFAP expression or distribution within the area. 
 While a number of studies have focused on diurnal changes of astrocytes within 
the SCN, relatively few experiments have examined diurnal properties of CNS astrocytes 
outside of the SCN.  Transgenic mouse models demonstrate that non-cerebellar CNS 
astrocytes exhibit endogenous circadian oscillations in expression of the core clock gene, 
Per2, when placed in culture.64  Per2 oscillates over 24 h, and this pattern becomes more 
robust when these astrocytes are co-cultured with hypothalamic slices containing the 
SCN.  These findings indicate that astrocytes undergo circadian changes in brain regions 
other than the SCN. 
Astrocyte Plasticity 
Under a wide variety of conditions, astrocytes undergo dynamic morphological 
changes in terms of size, filament length and position with respect to other cells.  This 
aspect of morphological change, termed astrocyte plasticity, may provide insights into 
the non-support functions of astrocytes within the brain.  GFAP is essential to this 
cellular behavior; its movement and reorganization contribute fundamentally to plasticity.  
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While proven to be a useful marker of the astrocyte cytoskeleton, GFAP may serve a 
more vital role in astrocyte function than previously considered. 
Astrocyte plasticity has been studied both in the hippocampus and in the SCN.  
Hippocampal astrocyte morphology responds to a variety of physiological conditions, 
including hormonal changes and development, and in disorders such as epilepsy.65-73  
Electron microscopy imaging of SCN astrocytes demonstrates that they contact specific 
populations of neurons,74 and their preferences vary depending on the time of day.  
Comparing two time points shows that astrocytes cover dendrites of VIPergic neurons in 
the SCN to a greater extent in the middle of the night relative to the early day, and 
coverage of AVP neurons shows a reversed relationship.62  Diurnal patterns of astrocyte 
association with VIP neurons depends on BDNF,75 a regulator of the photic entrainment 
pathway in the SCN.76,77  The influence of BDNF on astrocyte association with AVP 
neurons is unknown. 
Plasticity: Astrocyte Processes 
 Early studies of astrocyte plasticity focus on astrocytes in the supraoptic nucleus 
(SON) and their relationship to magnocellular neurons in the region.78-80  In conditions 
that change water balance such as dehydration, parturition and lactation, magnocellular 
neurons of the rodent SON come into close contact with each other primarily due to the 
retraction of astrocyte processes from between neuronal membranes.  The timing of 
astrocyte retraction during parturition matches the time of release of the neuropeptides 
oxytocin and vasopressin into the portal system of the blood from SON magnocellular 
neurons.  This finding indicates that the absence of astrocyte membranes between 
neurons may allow intensified neuronal communication via gap junction coupling, 
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facilitating coordinated firing and increased neuropeptide release.81  GFAP expression 
and morphology in the SON also vary in response to dehydration.  GFAP intensity and 
qualitative GFAP branch complexity are reduced upon dehydration when compared to 
non-dehydrated and rehydrated rats.82     
Retraction and extension of astrocyte processes modulate the ability of neurons to 
release the hormone oxytocin.  Osmotic stimulation of the SON provides reduced 
astrocyte coverage of oxytocin-secreting neurons.83  Astrocyte retraction subsequently 
allows increased secretion of oxytocin from synapses, and this facilitated hormone 
presence promotes remodeling of astrocyte processes, further increasing oxytocin 
vesicularization.  This cycle constitutes a positive feedback loop.84 
Specific molecular elements involved in astrocyte plasticity, particularly in the 
hypothalamic-pituitary region, have been identified.85  This region expresses molecules 
classically associated with tissue reorganization, including an isoform of a neural cell 
adhesion molecule, polysialic acid-neural cell adhesion molecule (PSA-NCAM,) and two 
glycoproteins, F3 and tenascin-C.  While PSA-NCAM and tenascin do not change in 
response to the stimulation that elicits astrocyte reorganization, the molecule F3 varies 
noticeably.  This suggests a role of F3 in promoting astrocyte plasticity.  
Plasticity: Astrocyte Swelling 
 A form of astrocyte plasticity that is classically separate from astrocyte process 
retraction is astrocyte swelling, in which an increase in the total astrocyte volume occurs.  
Hypoosmotic medium promotes influx of volume into the cell, and the actin cytoskeleton 
becomes diffuse throughout the cell body and concentrated at the tips of projections.86  
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While the actin cytoskeleton appears to be involved in swelling, cytochalasins, known 
destabilizers of the cytoskeleton, inhibit swelling but do not interfere with recovery. 
 Astrocyte swelling and specifically its influence on extracellular volume may 
directly modulate neurodynamics and neurochemical availability.87  Cell swelling reduces 
the volume of extracellular space, allowing less neurotransmitter to travel to nonsynaptic 
sites in neuron-neuron communication.  If the previously discussed retraction of astrocyte 
processes increases neuronal communication by prolonging the time that transmitter 
resides in the synapse, then swelling promotes a reverse effect, reducing neuron crosstalk.   
Another role for astrocyte swelling in CNS function addresses the mechano-
physical properties of astrocytes themselves.  Astrocytes in culture resist bursting from 
submersion in a hypotonic medium by relying on an extensive cytoskeletal network, 
while neurons are more prone to bursting due to a less resilient architecture.88  It may be 
that during osmotic stress, neurons utilize the more resistant cell bodies of astrocytes as 
“glial coverage” to minimize or counteract neuron bursting.   
Astrocyte Plasticity and the LH Surge 
Astrocyte plasticity has been described during day-night changes, looking 
specifically in relation to gonadotropin-releasing hormone (GnRH) neurons in the rostral 
preoptic area (rPOA).  In young ovulating rats, the surface area and GFAP process 
number of astrocytes in apposition to GnRH neurons in the rPOA decreases in late 
morning.  This change directly precedes a daily surge in luteinizing hormone (LH).  In 
middle-aged rats, day-night changes in GFAP surface area and process number do not 
take place, and these animals display less GFAP surface area and fewer processes.89   
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The SCN as central circadian timekeeper appears to be involved in day-night 
rPOA astrocyte changes.  Young rats treated with antisense mRNA to VIP in the SCN do 
not exhibit the previously described GFAP surface area changes in rPOA astrocytes.90  
The lack of day-night astrocyte rhythm in the rPOA observed with inhibited SCN VIP 
expression parallels the lack of rPOA astrocyte rhythm in middle-aged rats.  The findings 
suggest a necessity for SCN VIP in coordinating astrocyte plasticity that occurs during 
daily ovulatory hormone cycles.   
The Roles of Glial Fibrillary Acidic Protein 
 GFAP is an intermediate filament, but biochemically, it is similar to other 
cytoskeletal proteins, such as actin or microtubules.  Certain covalent modifications 
change the ability of the protein to polymerize: phosphorylation of GFAP by cAMP-
dependent protein kinase or protein kinase C prevents polymerization of GFAP while 
dephosphorylation returns the availability for polymerization.91  Astrocyte plasticity 
involves GFAP, but is there a physiological role of this intermediate filament beyond 
comprising astrocyte architecture?  
 Transgenic mice lacking GFAP demonstrate that the protein influences synaptic 
behavior in hippocampal neurons.92  Mice with GFAP deleted from their genomes exhibit 
enhanced long-term potentiation of neuron spike amplitude and increased post-synaptic 
potential slope relative to wildtype mice.  Thus, GFAP may modulate synaptic profiles 
through interactions of astrocyte processes with neurons.  Astrocytes lacking GFAP also 
display reduced accumulation of K+ in response to neuronal membrane depolarization, 
indicating greater extracellular space surrounding these astrocytes.93  Without the 
presence of GFAP, less swelling occurs, leading to attenuation of the physiological 
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consequences of swelling, such as ion efflux.  Swelling additionally occurs more slowly 
in GFAP-deficient astrocytes compared to wildtype astrocytes.  Together these 
observations support a role for GFAP in the mechanism of astrocyte swelling.  
 GFAP additionally interacts with the astrocyte glutamate transporter, GLAST.94  
Co-immunoprecipitation identified GLAST as a GFAP binding partner, and GLAST 
colocalizes with GFAP to a greater extent in brain cells from hypoxic animals compared 
to cells from unaffected brains.  This suggests that GFAP anchors GLAST more tightly to 
the plasma membrane of damaged cells, allowing continued transport of important 
transmitters during times of stress. 
 In disease regulation, the presence of GFAP may prevent the onset of certain 
neurological conditions, although unchecked GFAP production associated with 
astrogliosis can exacerbate disease and prevent cell regeneration.95  Dominant mutations 
in the GFAP gene have been identified as the primary cause of Alexander disease, a rare 
and devastating CNS disorder.96  Early onset Alexander disease is characterized by 
severe neurological symptoms including ataxia, seizures and developmental delays.97  In 
astrocytes, GFAP inclusion bodies known as Rosenthal fibers are a cellular hallmark of 
the condition.98  Most mutations in Alexander disease patients are de novo and dominant, 
although recessive transmission accounts for a small population of cases.99  Pathology as 
a result of GFAP mutations has been attributed to astrocyte dysfunction involving 
impaired Glu uptake100 and possibly dysfunctional potassium buffering leading to myelin 
loss.101  Treatment strategies include reduction of GFAP expression102 as well as recovery 
of lost Glu transporters through antibiotic stimulation.103 
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Summary, Aims and Significance 
 In many ways, the functional capacities of astrocytes within the CNS are little 
understood in terms of their relationships with neurons and with each other.  The 
influence of astrocyte activities on brain dynamics nonetheless reveal dynamic and often 
surprising functionality of these cells in serving the nervous system.  One such 
phenomenon is astrocyte plasticity, including retraction and extension of processes, 
swelling and shrinking of the cell body, and reorganization of astrocyte cytoskeletal 
proteins.  Most of the physiological goals assigned to the behavior of astrocyte plasticity 
fall under the category of supporting neuron function. 
 It may be that changes in astrocyte architecture serve not only to modulate neuron 
communication, but also to increase the efficacy of astrocyte-astrocyte interactions.  
Astrocytes have long been known to possess the ability to rapidly and dynamically 
interact with other astrocytes through signaling of calcium currents.104  If the changing 
morphology of astrocyte processes enhances synaptic strength between neurons, then this 
remodeling may just as plausibly alter the capacity of signaling between astrocytes. 
Regional heterogeneity of astrocyte morphology has been qualitatively observed 
in the cortex, amygdala, and brainstem.22  Nonetheless, there is no quantitative 
framework for assessing morphological differences between regional astrocyte 
populations, and similar analysis of daily morphological change in astrocyte populations 
is lacking.  The following studies include quantitative, high-resolution analysis of basal 
daily changes in the complexity of astrocyte cytoarchitecture and cell volume, comparing 
the DG and SCN within the same brains.  With diurnal astrocyte morphology change 
documented in these regions, it is still unclear whether dynamics are facilitated by 
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turnover of intermediate filaments or by reorganization of protein that is already present.  
The described work uses Western blot protein quantification to determine whether GFAP 
levels change across the day, supporting filament turnover, or whether they remain 
stagnant, supporting filament reorganization.  Although light has been found to influence 
SCN GFAP distribution,45-47 the effect of light on diurnal astrocyte morphology rhythms 
is undefined.  Studies described here evaluate the consequences of constant light 
deprivation, light pulses, and Glu, the chemical signal of light, to determine their 
contributions in modulating hippocampal and SCN astrocyte morphology. 
Finally, dehydration causes dynamic astrocyte remodeling in the SON, but 
quantification of the associated GFAP changes has not been performed.  The capacity of 
dehydration to alter astrocyte structure in the DG and SCN is also unexplored.  The 
mechanism of SON GFAP structural change, either through GFAP turnover or 
reorganization, is unclear.  Dehydration studies in these areas may demonstrate additional 
differences between brain regions in stimulated astrocyte changes. 
The specific aims addressing diurnal changes in astrocyte morphology are as 
follows: 1) Determine the extent of diurnal plasticity in astrocyte morphology of the 
rodent DG and SCN, 2) Determine the importance of light in mediating diurnal astrocyte 
morphology change in the DG and SCN, and 3) Determine the extent of astrocyte 
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CHAPTER 2.  DIURNAL CHANGES IN ASTROCYTE MORPHOLOGY OF THE 
DENTATE GYRUS AND SUPRACHIASMATIC NUCLEUS 
 
Introduction 
 Astrocytes are known to respond morphologically to physiological stress,79,80 and 
several reports have suggested that astrocytes in the suprachiasmatic nucleus (SCN) 
change shape across the day-night cycle.62,63  No study, however, has quantified daily 
morphological change in any brain region without the presence of exogenous stimuli 
other than day-night cues.  Similarly, morphological divergence between astrocytes of 
separate brain regions has been qualitatively observed,22 but no quantitative framework 
exists for differentiating astrocytes based on morphological characteristics.  It is 
furthermore unknown whether the day-night cycle influences astrocyte morphology 
uniformly across brain regions. 
 GFAP is the primary intermediate filament of many adult astrocyte 
populations,115 and as a key cytoskeleton component, its morphological dynamics may 
reflect widespread cell shape changes.  Previous studies examining diurnal morphological 
change in the SCN have qualitatively described cytoskeleton distribution,63 or they have 
quantitatively measured percentage of neuronal membrane in contact with astrocytes.62,116  
No study of daily morphological change in SCN astrocytes has quantified specific 
parameters such as GFAP branch terminal-point number of individual cells.  Thus, the 
first priority in this aim is to examine whether GFAP filament complexity, represented by 
GFAP branch terminal-point number, changes across the day.   
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The dentate gyrus (DG) in the mammalian hippocampus is a favored hippocampal 
region for astrocyte morphology studies.24-26  Moreover, key regulators of hippocampal 
learning and memory change with a diurnal rhythm in the DG.28,30  Brain-derived 
neurotrophic factor (BDNF) mRNA and its target, the TrkB receptor, modulate levels 
with day-night rhythms in the DG.  Only one other area in the hippocampus, the CA3 
region, demonstrates diurnal expression of both molecules.  The DG is an ideal brain 
region for diurnal astrocyte morphology studies outside of the SCN.   
Overall complexity in GFAP structure may change across the day in both the DG 
and SCN.  This alone would not reveal whether morphology changes are facilitated by 
daily GFAP turnover or by reorganization of existing GFAP.  A number of studies have 
sought to determine whether GFAP levels fluctuate across the day.58,61,62  These 
experiments relied on qualitative or semi-quantitative analysis of GFAP 
immunoreactivity within fixed tissue.  Quantification of Western blot protein bands 
focused by charge and molecular weight is a more reliable and accurate approach to 
determining relative protein content within tissue.  This method is used in the following 
studies to observe diurnal GFAP levels in the DG and SCN.   
Widespread cell shape changes beyond the cytoskeleton may also occur over the 
diurnal timeframe.  GFAP does not necessarily reflect overall cell morphology such as 
shape defined by the cell membrane.117,118  Utilization of a transgenic GFAP-GFP mouse 
helps to address this concern.  In the GFAP-GFP mouse, green fluorescent protein (GFP) 
is expressed under the promoter for GFAP.  GFP fills the cytoplasm of GFAP-positive 
cells, allowing more complete visualization of cell shape and cell volume.  This model 
allows assessment of astrocyte morphology change across the day. 
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The following studies address the specific aim: Determine the extent of diurnal 
plasticity in astrocyte morphology of the rodent DG and SCN.  The following sub-aims 
are evaluated: 1) Determine the extent of diurnal GFAP morphology change in DG and 
SCN astrocytes, 2) Assess whether GFAP protein levels change across the day in the DG 
and SCN, and 3) Determine the extent of diurnal volume change in SCN astrocytes. 
 
Materials and Methods 
Animal and Tissue Preparation 
  Long Evans/BluGill male and female rats (University of Illinois, Urbana, IL) aged 
10-20 weeks were used for this study.  Animals were entrained to a 12 h light:12 h dark 
schedule. Zeitgeber time (ZT), reckoned according to the timing of light, starts with 
lights-on; accordingly, ZT 2 is 2 h after lights-on, and ZT 14 is 14 h after lights-on (also 2 
h after lights-off).  To prepare brain tissue for immunohistochemistry, rats were injected 
subcutaneously with approximately 1 mL of Euthasol at the appropriate ZT and perfused 
transcardially with 300 mL of 4% paraformaldehyde (PFA).  Brain tissue was sliced into 
40 µm sections using a vibratome. 
  GFAP-GFP mice (Jackson Laboratories, Bar Harbor, ME) contain a transgene 
with a GFAP promoter driving expression of green fluorescent protein (GFP).  GFP 
diffuses throughout the cytoplasm of astrocytes, and because this transgene is expressed 
robustly in the SCN, GFP effectively reports SCN astrocyte morphology.  This transgene 
does not express in the hippocampus, likely due to the genome insertion site.  Mice 10-20 
weeks old of both sexes were used for this study.  GFAP-GFP mice were euthanized with 
approximately 0.1 mL Euthasol, then perfused transcardially with 50 mL of 4% PFA. 
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Immunohistochemistry 
  Tissue sections were incubated with a primary monoclonal antibody against 
GFAP (Millipore, Billerica, MA) at a concentration of 1:10,000 for 1 h at room 
temperature and a secondary 488-nm wavelength goat anti-mouse antibody (Life 
Technologies, Grand Island, NY) at 1:1,000 for 1 h at room temperature.  Sections were 
treated with diamidinophenylindole (DAPI) (Life Technologies), a fluorescent blue dye 
that binds specifically to chromatin.  Each sample consisted of all hippocampal and SCN 
slices collected at each time point.  All samples for each n were stained simultaneously.  
Microscopy and Image Analysis 
  To observe GFAP-labeling, a laser-equipped LSM-510 confocal microscope 
(Zeiss, Oberkochen, Germany) was used.  Twenty images separated by 0.5 µm in 
thickness comprised a 3-dimensional 10 µm-thick z-stack of the tissue.  Analysis of the 
hippocampus focused on the molecular layer of the DG in the most ventral area of the 
DG, ventral to the granular layer, to avoid GFAP-positive neuroprogenitors in the 
granular layer.  Analysis of the SCN focused on the mid-section SCN on either side of 
the bilaterally paired nuclei.  
  Images were processed using Imaris software (Bitplane, South Windsor, CT) to 
reconstruct the cytoskeletal architecture from GFAP labeling of the astrocytes.  When the 
software reconstructed branch areas that were clearly not present in images or, conversely, 
when clearly visible branch areas were omitted by software reconstruction, these 
reconstructions were not included in data collection.  Otherwise, all reconstructed cells in 
the fields of view contributed to data analysis.  Cell starting-point diameter, the 
maximum possible branch thickness for a field of view, was selected as 8 µm in the DG 
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and 5 µm in the SCN.  Cell seed-point diameter, the minimum possible thickness for a 
field of view, was selected as 0.5 µm for both the DG and the SCN.  This may reflect the 
resolution limit of the analysis. 
  Starting-point distribution and seed-point distribution for fields of DG and SCN 
astrocytes labeled with GFAP are presented in Fig. 2.1A.  The software reconstructs cell 
morphology using an algorithm that traces cellular branches by recognizing differences in 
local contrast between signal and background fluorescence intensity.  Accordingly, the 
ratio between signal and background is optimized for each region of interest (ROI) when 
acquiring images.  The software provides numerical data such as branch terminal-point 
number/cell.  A branch terminal-point exists every time that a branch ends without 
continuing to form another branch.  
  Volume measurements in the GFAP-GFP mouse were obtained by determining 
the total GFP-filled volume for a given ROI.  This value was then divided by the total 
number of GFP-positive cells, distinctly visible by cell somas, in the ROI.  This number 
provides an average volume/cell value for the ROI, which contributes to several 
volume/cell ROI values for a given SCN.    
Western Blot Protein Quantification 
  Total protein (15 µg/sample) was resolved in 8% SDS-PAGE and transferred to 
polyvinyldifluoride (PVDF) membranes (Bio-Rad, Hercules, CA).  Membranes were 
probed with a 1:10,000 dilution of mouse anti-GFAP antibody (Millipore) for 1 h at room 
temperature, a 1:10,000 dilution of goat anti-mouse antibody (Life Technologies) for 1 h 
at room temperature, and developed with SuperSignal Chemiluminescent Substrate 
(Pierce, Rockford, IL).  After scanning, an anti-tubulin antibody (Cell Signaling, Danvers, 
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MA) was applied at a 1:5,000 dilution for 1 h at room temperature, followed by a 
1:10,000 dilution of goat anti-mouse antibody (Life Technologies).  GFAP levels were 
determined by the intensity of the single GFAP band [molecular weight (MW) = 50 kD] 
over the intensity of the band labeled by anti-tubulin (MW = 55 kD) in the same lane, to 
control for possible unequal sample loading.   
  Western blots were completed with the assistance of James Chu. 
Statistical Analysis 
Statistical analysis was performed using SAS statistical software (version 9.2).  
Due to the nature of mean branch terminal-point values representing multiple cells/n/time 
point, mixed-model ANOVA was used with Tukey’s post-hoc comparison.  When 
analyzing DG astrocyte morphology simultaneously with SCN astrocyte morphology at 
all time-points (Fig. 2.2), a two-way mixed model ANOVA was used.  Factor 1 was brain 
region with 2 levels: the DG and SCN.  Factor 2 was time of day with 6 levels: 6 time 
points.  The random effect for this analysis was the individual animal to account for the 
correlation between the multiple measurements of cells within individuals.  For volume 
measurement analysis, one-way two-level mixed model ANOVA was used.  The fixed 
effect was the condition (time).  
For protein level analysis in the DG and SCN at multiple time points, one-way 
ANOVA was used with Tukey’s post-hoc comparison.  
For all analyses other than Western blot, data were log-transformed to reduce 
skewness and to improve normality of the data, allowing parametric tests. 




GFAP morphologies in the DG and SCN show time-of-day and region-specific 
differences 
  Analysis of branch terminal-points for both DG and SCN together indicates 
highly significant effects of time and brain region, and an interaction between time and 
brain region.  The time-of-day effect is region-specific: at times when terminal-point 
number increases in the DG, it decreases in the SCN, and vice-versa (Fig. 2.2B, D).  
Branch terminal-points in the SCN are significantly more numerous than in the DG 
across the day-night cycle.  
GFAP morphologies change with a diurnal rhythm in the DG and SCN 
  Branch terminal-points in the DG reach their maximum value of 90 ± 5 terminal-
points at ZT 14, 2 h into night, and they reach their minimum value of 61 ± 1 terminal-
points at the end of the night at ZT 22 (Fig. 2.2A, B).  We found a significant diurnal 
oscillation in the DG across the 24-h light-dark cycle.  Post-hoc analysis shows values 
significantly different between ZT 2 and 14 (p = 0.035) and between ZT 14 and 22 (p 
= .038).  The number of terminal-points at the trough at ZT 22 increases 47% to the peak 
level at ZT 14.  
  In the SCN, branch terminal-points reach their maximum value of 420 ± 76 
terminal-points at ZT 2, and their minimum value of 127 ± 8 terminal-points at ZT 14 
(Fig. 2.2C, D).  This >3X change in the SCN is a highly significant diurnal oscillation. 
Post-hoc analysis shows values significantly different between ZT 2 and 14 (p < 0.0001), 
between ZT 2 and 18 (p = 0.020), between ZT 6 and 14 (p < 0.0001), between ZT 10 and 
14 (p = 0.011), between ZT 14 and 18 (p = 0.042) and between ZT 14 and 22 (p = 0.015).  
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The trough level at ZT 14 undergoes a 330% increase to the peak level at ZT 2.  The 
difference in branch terminal-points between peak and trough is a ~10X greater change in 
the SCN than in the DG.  This pattern of changing complexity in the SCN is inverted 
from the DG pattern (Fig. 2.2B, D). 
GFAP levels do not change diurnally in the DG or in the SCN 
 GFAP protein levels in DG tissue, collected at the same 6 ZT time points as tissue 
for analysis of cytoskeleton morphology across the day, does not show any significant 
diurnal oscillation (Figure 2.3A).  Similarly, GFAP in SCN tissue, collected at these same 
time points, does not show significant changes in protein level across the day (Figure 
2.3B). 
SCN astrocyte volume changes diurnally alongside GFAP branch complexity 
  Based on the volume of the GFP-filled space in cells of the GFAP-GFP transgenic 
mouse, SCN astrocyte volume/cell is significantly greater in the early day at ZT 2 than at 
early night at ZT 14 (Fig. 2.4A, B).  Although the astrocyte soma appears smaller in 
volume at ZT 2 compared to ZT 14, the total volume per cell at ZT 2 is greater than at ZT 
14.  GFP-filled arborization also appears more extensive at ZT 2.  The ZT 2 astrocyte 
volume is 4905 ± 308 µm3, whereas at ZT 14 it is 3876 ± 127 µm3, a volume change of 
26% from the ZT 2 value (Fig. 2.4C).  These changes accompany significant GFAP 
terminal-point changes in the same animals (Fig. 2.4A, B).  GFAP branch terminal-points 
in the transgenic mouse are 117 ± 3 terminal-points at ZT 2, and branch terminal-points 
are 80 ± 0.4 terminal-points at ZT 14, a 46% change in complexity (Fig. 2.4D). Lack of 
GFP expression in the transgenic mouse hippocampus, presumably due to transgene 
insertion effects, prevented similar volumetric analysis in the hippocampus. 
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Discussion 
  These findings demonstrate that diurnal structural changes in astrocytes exist in 
multiple areas of the brain.  Such changes taking place in the SCN are suggested by 
multiple reports, but quantifiable “around-the-clock” studies had not been completed.  
Such changes occurring outside of the SCN are previously undescribed phenomena, and 
volume changes accompanying diurnal cytoskeletal patterns are novel contributions to 
astrocyte plasticity.  Astrocyte cell volume changes between ZT 2 and ZT 14, decreasing 
significantly from early day to early night.  Data that reveal volume fluctuations in 
parallel with GFAP remodeling suggest that GFAP structure helps determine overall 
astrocyte shape. 
 Previous studies have attempted to determine whether GFAP oscillates with any 
discernible diurnal or circadian rhythm in the SCN by using immunoreactivity in tissue 
sections.58,61,62,74  Outside of the SCN, little attention has been paid to astrocyte rhythms, 
and no study has addressed whether GFAP levels rhythmically change in non-SCN 
regions.  Previous studies do not provide a conclusive answer owing both to 
methodological concerns and conflicting results.  Western blot analysis is preferable to 
immunohistochemistry (IHC) quantification due to its more rigorous normalization using 
control protein levels.  Also, when comparing Western blot samples, data for comparison 
are present on the same gel, whereas IHC comparisons are frequently performed using 
images taken at separate times.    
The studies reported here show that biosynthetic turnover is unlikely to account 
for the morphological changes we report.  The half-life of a GFAP molecule is 
approximately 7.5 days in cultured rat astrocytes, measured using immunoradiometric 
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assays.119  However, assembly that increases branch terminal-point number greater than 
threefold occurs over 12 h in the SCN while total GFAP levels do not fluctuate.  
Therefore, dynamic assembly and disassembly of GFAP filaments must underlie diurnal 
changes.  In vitro, purified GFAP in the presence of regulatory proteins can polymerize 
and depolymerize in minutes.120-122  Should filament dynamics of comparable speed 
occur in the intact brain, this would allow branches to form and disassemble in the 
timeframes we observe. 
  Astrocyte morphologies defined by GFP in the transgenic mouse are comparable 
to those observed in previous studies of total astrocyte morphology, using either 
transgenic mice or dye-filling of individual astrocytes.22,117,118  Elaborate spongiform 
processes surround highly fluorescent cell somas in each model.  No previous study used 
volume labeling of astrocytes to observe diurnal differences in the brain.  In the data 
presented, percent branch terminal-point changes are approximately twice those of 
percent volume changes.  It may be that cytoskeletal remodeling contributes to functions 
unrelated to overall morphology change in addition to volume phenomena.    
  Changes observed in astrocyte morphology may contribute to a cell-swelling 
mechanism mediated by remodeling of the GFAP cytoskeleton.  Indeed, astrocyte 
intermediate filaments are necessary for astrocyte regulatory volume decrease after cell 
swelling under hypotonic conditions.93,123  It is not known whether a changing ionic 
milieu contributes to morphological rhythms in SCN astrocytes.  However, ZT 2 marks 
the point in the day-night cycle when spontaneous neuronal activity is increasing and 
when ion fluxes would be more active than at ZT 14, when neuronal excitability is 
lowest.124 
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  With rapidly improving techniques, additional insights may emerge from higher-
resolution reconstructions.  Complex fine structures of astrocytes have been achieved 
from reconstructions based on genetically encoded calcium indicators (GECIs).125,126  
This approach uses electroporation or viral transfection to introduce GECIs comprised of 
1-2 fluorescent proteins whose emissions are modulated by a Ca2+-sensing domain.  
Fluorescence changes report Ca2+-fluxes in fine processes, even end-feet.127  This 
approach is a marked improvement over bulk-loading of Ca2+ indicators via patch pipette, 
which fails to reveal complex morphologies and can alter astrocyte physiology.   
  Astrocyte volume labeling with GFP is preferable to GECI labeling for the 
purposes of the presented studies.  GECI techniques label all neurons and glia within a 
region and require Ca2+ fluxes/binding to generate a signal, thus careful titration is 
required for imaging processes of single cells.  In comparison, GFP is autocatalytic, 
requiring no exogenous cofactors, is stably expressed, and is targeted via the GFAP 
promoter to this subclass of astrocytes for the life of the animal.  While GECIs are tools 
of choice when evaluating Ca2+ signaling, for morphologial studies the transgenic 
approach circumvents the need for  surgery, careful titration, and risks of cellular toxicity 
after prolonged expression of GECIs.128 
  These studies establish a quantitative framework for analyzing astrocyte 
cytoskeleton morphology, and they have defined diurnal patterns of these morphologies 
in two areas of the brain.  A natural step forward would be to analyze putative rhythms in 
other areas of the brain and possibly even GFAP-positive cells outside of the brain, such 
as those evident in the enteric nervous system.129,130  Astrocyte morphology rhythms in 
non-SCN regions other than the DG may also be in antiphase to SCN rhythms, a 
 26	  
possibility that could be pursued by future work.  It would be furthermore intriguing to 
know the role of the SCN and its astrocytes in maintaining the coherence of astrocyte 


























Fig. 2.1. Reconstruction of the astrocyte cytoskeleton and experimental design.  (A) 
Raw GFAP immunofluorescence in the molecular layer of the rat dentate gyrus (DG) and 
in a mid-section of the suprachiasmatic nuclei (SCN) (top). Dotted lines represent the 
border of the granular layer of the DG and the boundaries of a single SCN, respectively.  
Immunofluorescence of the cell soma is the basis for identifying separate cells with 
defined maximum and minimum branch diameters using Imaris imaging software 
(middle). The software reconstructs the GFAP cytoskeleton, allowing each cell to be 
recognized and branch complexity to be analyzed (bottom). (B) Schematic for 
experimental design. Rats are entrained to a 12 h light:12 h dark cycle, and brain tissue is 
collected every 4 h, starting at Zeitgeber time (ZT) 2. Scale bars = 50 µm.  
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Fig. 2.2. Dentate gyrus and SCN astrocytes exhibit diurnal rhythms and regional 
heterogeneity in cell morphology.  (A) Astrocytes in the DG display a less branched 
pattern at ZT 2 compared to ZT 14. (B) GFAP branch terminal-point number/cell in the 
DG changes significantly across the day-night cycle (F5,18 = 3.44, p = 0.023, two-level 
mixed model ANOVA, * = p < 0.05, Tukey’s post-hoc comparison). (C) SCN astrocytes 
display a more highly branched pattern at ZT 2 vs. ZT 14. (D) GFAP branch terminal-
point number/cell in the SCN changes significantly across the day-night cycle (F5,18  = 
12.07, p < 0.0001, two-level mixed model ANOVA, *** = p < 0.0001, * = p < 0.05, 
Tukey’s post-hoc comparison). Analysis of DG and SCN terminal-points indicates 
significant effects of time (F5,36 = 4.92, p = 0.0016) and brain region (F1,36 = 471.50, p < 
0.0001), and an interaction between time and brain region (F5,36 = 14.72, p < 0.0001). 
SCN astrocytes are more highly branched than DG astrocytes at all times examined (p < 
0.0001, two-level mixed model ANOVA). Error bars represent SEM, n = 4 brains/time-
point, 14-42 cells/DG sample, 10-36 cells/SCN sample. Scale bars = 50 µm top panels, 





















Fig. 2.3. Total levels of GFAP protein in the DG and SCN do not fluctuate across the 
day. (A) GFAP protein levels in the DG do not significantly change across the day-night 
cycle (F5,18 = 0.95, p = 0.46, ANOVA). (B) GFAP protein levels in the SCN do not 
change across the day-night cycle (F5,18 = .037, p = 0.99, ANOVA). n = 4 brains/time 






Fig. 2.4. SCN astrocyte volume changes align with changes in cytoskeletal 
architecture.  (A, B) GFP (green) in SCN of transgenic GFAP-GFP mice exhibits a 
wider distribution and more extensive branching at ZT 2 (A) relative to ZT 14 (B). GFAP 
(red) is more highly branched in these mice at ZT 2 (A) relative to ZT 14 (B). (C) GFP 
volume is significantly greater at ZT 2 than at ZT 14 (F1,6 = 9.67, p = .021, * = p < 0.05, 
two-level mixed model ANOVA). Volume/cell is determined by dividing total ROI 
volume by number of GFP-positive astrocytes in the ROI. (D) Branch terminal-point 
value/cell is also significantly different between ZT 2 and ZT 14 (F1,4 = 83.3, p = 0.0008, 
** = p < .005). Error bars represent SEM, n = 4 brains/time point for volume, ZT 2 = 18 
ROIs, ZT 14 = 20 ROIs, n = 3 brains/time point for GFAP, 15-24 cells/SCN sample. 
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Light is the fundamental cue responsible for the day-night cycle and its transitions.  
In the retina, light stimulates intrinsically photoreceptive retinal ganglion cells 
(ipRGCs),131 beginning a signaling cascade involving G protein-coupled receptors 
(GPCRs), pituitary adenylate cyclase-activating peptide (PACAP) and glutamate 
(Glu).132-135  ipRGCs project to numerous areas of the brain, conveying information to the 
suprachiasmatic nucleus (SCN), intergeniculate leaflet (IGL), olivary pretectal nucleus 
(OPN), amygdala, and superior colliculus, among several other regions.136   
Light-dark rhythms modulate learning and memory formation that takes place in 
the hippocampus.  In fear conditioning tasks, mice entrained to 12 h light:12 h dark 
cycles learn best during the light phase and worst during the dark phase, and this pattern 
persists when animals are entrained to reversed lighting schedules.137  However, rapidly 
shifting the light-dark cycle by 6 or 12 h immediately after fear conditioning dramatically 
reduces the efficacy of learning.138  This implies that placing animals in light-dark cycles 
that are out of phase with their endogenous rhythms attenuates learning, and these 
endogenous rhythms contribute to successful memory formation.  Indeed, the molecular 
circadian clock may play a vital part in memory consolidation.139  
In the mammalian SCN, Glu is the chemical messenger of light, and it establishes 
the phase of neuronal circadian rhythms.46,140-142  SCN astrocytes are also responsive to 
light signaling.  Light deprivation as a consequence of enucleation dramatically reduces 
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the density and distribution of SCN glial fibrillary acidic protein (GFAP).57  Maintaining 
animals in constant light has a similar effect on SCN GFAP.58  Brain-derived 
neurotrophic factor (BDNF) regulates the photic entrainment pathway in the SCN.76,77  
Specifically, mice deficient in either BDNF or TrKB, a BDNF receptor, display 
attenuated phase shifts in wheel-running behavior in response to light pulses at night.  
BDNF also plays a key role in promoting diurnal changes in astrocyte membrane 
apposition with VIPergic neurons in the SCN.76  Although the present study does not 
evaluate astrocytes associated with VIPergic neurons, this evidence implicates light in the 
regulation of daily astrocyte morphology rhythms. 
 Entrainment to 24-h light:dark cycles produces diurnal GFAP structure rhythms in 
the dentate gyrus (DG) and SCN (Fig. 2.2), but whether or not light is actually necessary 
to observe morphology oscillations is unknown.  Diurnal rhythms in astrocyte 
morphology exist in the regions examined, but these rhythms are not in phase between 
regions, and different astrocyte populations may respond differently to the same cues.  It 
is possible that cells in the DG and SCN respond differently to light, the driving force 
behind the day-night cycle.  The following studies contribute to a broader understanding 
of astrocyte heterogeneity within the brain.  It is additionally unknown whether light is 
sufficient for astrocyte morphology remodeling.  The experiments undertaken assess 
whether light plays a causative role in diurnal changes in GFAP morphology. 
 The following studies address the specific aim: Determine the role of light in 
mediating diurnal astrocyte morphology rhythms.  The following sub-aims are evaluated: 
1) Determine whether light is necessary for diurnal rhythms in DG and SCN GFAP 
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morphology, and 2) Determine whether light is sufficient for diurnal rhythms in DG and 
SCN GFAP morphology.  
 
 Materials and Methods 
Animal and Tissue Preparation   
  Long Evans/BluGill male and female rats (University of Illinois) aged 10-20 
weeks were used for this study.  Animals in constant dark were entrained to 12 h light:12 
h dark schedule for 10 d before being placed into constant dark for 3 d.  While in constant 
dark, animals are free-running under circadian time (CT) governed by temporal 
organization of the intrinsic circadian clock.  CT 2 corresponds to 2 h after lights-on in 
the entraining lighting cycle, and CT 14 corresponds to 14 h after lights-on and 2 h into 
subjective night.  Rats were sacrificed at CT 2 and CT 14 in the dark.  
  Animals subjected to a light pulse were given 15 min of light at zeitgeber time 
(ZT) 14, then 30 min of darkness before sacrifice.  Controls remained in darkness during 
this period and were harvested at the same time point.  
  Rats were injected subcutaneously with approximately 1 mL of Euthasol at the 
appropriate ZT and perfused transcardially with 300 mL of 4% paraformaldehyde (PFA).  
Brain tissue was sliced into 40 µm sections using a vibratome. 
Glu is the chemical messenger of light in the SCN.46,140-142  Glu receptor 
antagonists 2-amino-5-phosphonopentanoic acid (AP5) and 2,3-dihydroxy-6-nitro-7-
sulfamoyl-benzo(f)quinoxaline-2,3-dione (NBQX), inhibitors of NMDA and AMPA 
receptors respectively, are used to prevent Glu communication in organotypic slice 
cultures.140,143-145  Incubating slices with Glu and Glu in conjunction with these inhibitors 
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may provide support for the importance of light signals in diurnal astrocyte rhythms.  
Treatment of slices with these inhibitors alone in the absence of Glu may yield new 
insights into endogenous Glu signaling separate from light cues and the maintenance of 
unstimulated astrocyte morphology. 
  Brain slices to be treated with Glu and/or inhibitors of Glu receptors were 
prepared as 500 µm coronal slices and placed in the center of Hatton-style brain slice 
chambers containing Earle’s Balanced Salt Solution (EBSS) (Life Technologies), 
supplemented with 26 mM glucose, 10 mM NaHCO3 and .005% gentamicin.144  Animals 
were sacrificed at ZT 7, and slices were placed into chambers and continuously perifused, 
except during treatment at CT 14 with either 1 µL of 10 mM Glu or a microdrop of Glu 
with a bath of 5 µM NBQX (AG Scientific, San Diego, CA) and 20 µm AP5 (Tocris, 
Bristol, UK), or NBQX and AP5 alone.  These treatments have been shown to modulate 
Glu signaling pathways without long-term detrimental effects on the health of the 
tissue.140,144  
  For Glu treatments, a 1 µL drop was placed directly onto bilateral SCN tissue at 
CT 14 for 10 min, followed by 30 min EBSS washout.  For treatments of Glu with 
inhibitors of Glu receptors, slices were placed in a static inhibitor bath.  At 20 min, 1 µL 
drops of Glu with inhibitors were applied directly onto SCN tissue at CT 14 for 10 min, 
followed by EBSS washout.  For inhibitor treatment alone, slices were placed in a static 
inhibitor bath for 30 min at the same CT as experiments, followed by EBSS washout.  
Hippocampal slices were treated with a 10 µM Glu146 static bath at CT 14 for 10 min, 
followed by EBSS washout.  Post-washout, brain slices were fixed immediately in PFA 
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for 1 h, then 30% sucrose for ≥ 12 h.  Both SCN and hippocampal slices were sectioned 
at 20 µm by cryostat. 
  Fig. 3.1 provides a schematic for constant dark, light pulse, and Glu/inhibitor 
experiments.   
  Dr. Jennifer Mitchell prepared, treated and cryostat-sectioned SCN and 
hippocampal brain slices. 
Immunohistochemistry 
  Tissue sections were incubated with a primary monoclonal antibody against 
GFAP (Millipore) at a concentration of 1:10,000 for 1 h at room temperature and a 
secondary 488-nm wavelength goat anti-mouse antibody (Life Technologies) at 1:1,000 
for 1 h at room temperature.  Sections were also treated with diamidinophenylindole 
(DAPI) (Life Technologies) to visualize nuclei.  Each sample consisted of all 
hippocampal and SCN slices collected at each time point or condition.  All samples for 
each n were stained simultaneously.  
Microscopy and Imaging Analysis 
  A laser-equipped LSM-510 confocal microscope (Zeiss) was used to observe 
GFAP labeling.  Twenty images separated by 0.5 µm in thickness comprised a 3-
dimensional 10 µm-thick z-stack of the tissue.  Analysis of the hippocampus focused on 
the molecular layer of the DG in the most ventral area of the DG, ventral to the granular 
layer, to avoid GFAP-positive neuroprogenitors in the granular layer.  Analysis of the 
SCN focused on the mid-section SCN on either side of the bilaterally paired nuclei.  
Images were processed using Imaris software (Bitplane) to reconstruct the cytoskeletal 
architecture from GFAP labeling of the astrocytes.  
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Western Blot Protein Quantification 
  Total protein (15 µg/sample) was resolved in 8% SDS-PAGE and transferred to 
polyvinyldifluoride (PVDF) membranes (Bio-Rad).  Membranes were probed with a 
1:10,000 dilution of mouse anti-GFAP antibody (Millipore) for 1 h at room temperature, 
a 1:10,000 dilution of goat anti-mouse antibody (Life Technologies) for 1 h at room 
temperature, and developed with SuperSignal Chemiluminescent Substrate (Pierce).  
After scanning, an anti-tubulin antibody (Cell Signaling) was applied at a 1:5,000 dilution 
for 1 h at room temperature, followed by a 1:10,000 dilution of goat anti-mouse antibody 
(Life Technologies).  GFAP levels were determined by the intensity of the single GFAP 
band [molecular weight (MW) = 50 kD] over the intensity of the band labeled by anti-
tubulin (MW = 55 kD) in the same lane, to control for possible unequal sample loading.   
  Western blots were completed with the assistance of James Chu. 
Statistical Analysis 
  For analyses of GFAP morphology in constant dark and GFAP morphology after 
a light pulse at ZT 14, one-way two-level mixed model ANOVA was used.  The fixed 
effect for these analyses was the condition (time, light pulse).  For protein level analysis 
following a light pulse at ZT 14, Student’s t-test was used.  For analysis of Glu and/or 
Glu receptor inhibitor treatment, one-way four-level mixed model ANOVA was used 
with Tukey’s post-hoc comparison.  The fixed effect for this analysis was the condition: 
control, Glu, Glu with inhibitor, or inhibitor alone treatment.  Except for light pulse and 
Western blot studies, data were log-transformed to reduce skewness and to improve 
normality of the data, allowing parametric tests. 
  Statistical analysis was performed with the assistance of Dr. Justin Rhodes. 
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Results 
Animals maintained in constant darkness do not show changes in GFAP morphology in 
DG or SCN astrocytes 
  Whether light is necessary for diurnal GFAP shape dynamics is not known.  A 
study that places animals in constant darkness and evaluates whether astrocytes undergo 
circadian shape changes would provide direct evidence in response to this question.  
  Rats kept in constant dark for 3 d were sacrificed at CT 2 and CT 14 to determine 
whether astrocytes maintain GFAP morphology rhythms under free-running conditions.  
The number of DG GFAP branch terminal-points at CT 2 is not significantly different 
from the number of DG branch terminal-points at CT 14 (Figure 3.2A, B).  Likewise, 
SCN GFAP branch terminal-point number at CT 2 is not significantly different from CT 
14 (Figure 3.2C, D).  
Light exposure in early night causes rapid and opposite remodeling of astrocyte 
morphology in the DG and SCN 
  To determine whether nocturnal light influences astrocyte morphology, we 
evaluated astrocyte morphology after acute, brief exposure to light.  In the DG, animals 
not exposed to light display 83 ± 4 branch terminal-points.  DG branch complexity 
decreased to 68 ± 2 branch terminal-points by 30 min after animals were exposed to 15 
min of light at ZT 14 (Fig. 3.3A, B).  This is a significant change from the level when the 
animal remains in the dark.  This decline represents a 22% decrease in branch terminal-
points compared to the unstimulated value.  
  The same animals used for analysis in the DG were used to evaluate effects of 
light on SCN astrocytes.  In the SCN at ZT 14, animals not exposed to light display a 
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branch terminal-point value of 96 ± 7 terminal-points.  Animals that received a light 
pulse at ZT 14 display a branch terminal-point value of 132 ± 11 terminal-points, a 
significant increase from the unpulsed control value (Fig. 3.3C, D).  This represents a 
38% increase in branch terminal-points over the control value, and an opposite and larger 
change than effects on DG astrocytes.  
GFAP levels do not change in the DG or in the SCN in response to a light pulse in early 
night 
 Animals were subjected to a 15-min light pulse at ZT 14, early night, and after 30 
min of darkness, animals were sacrificed, identical to the procedure for analysis of 
astrocyte morphology after light stimulation.  GFAP protein levels in the DG do not 
significantly change after a light pulse, relative to unpulsed controls sacrificed at the 
same time (Figure 3.4A).  SCN GFAP levels also do not change after a light pulse, 
relative to controls (Figure 3.4B).  
Glu treatment in early night causes astrocyte remodeling in SCN but not DG brain slices 
  In order to evaluate the possible role of Glu signaling in mediating astrocyte 
structural remodeling, acute DG and SCN brain slices were treated with Glu at the 
equivalent CT to when light was tested in intact animals.  DG slices treated with 
microdrops of Glu exhibited 75 ± 2 terminal-points/cell at 40 min after Glu application, 
not significantly different from controls treated with EBSS (77 ± 2 terminal-points) (Fig. 
3.5A, B).  When SCN slices were treated with Glu under the same conditions, astrocyte 
terminal-points increased by 33% within 30 min, from 121 ± 8 to 161 ± 5 terminal-points, 
a highly significant change from controls (Fig. 3.5C, D).  This is comparable to the 38% 
increase observed in the SCN when treated with a light pulse at early night. 
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Glu receptor inhibition prevents Glu-induced astrocyte remodeling in the SCN and 
changes basal astrocyte architecture 
  To determine whether inhibiting neurotransmission via Glu receptors could 
interfere with Glu-induced changes in SCN astrocyte structure, a Glu receptor inhibitor 
cocktail was used.  Slices were treated with Glu in the presence of the AMPA receptor 
antagonist NBQX and NMDA receptor antagonist AP5.  A significant difference was 
found between all treatment groups in an ANOVA test (Fig. 3.5D).  SCN astrocytes 
treated with Glu and receptor inhibitors displayed 76 ± 3 terminal-points/cell, 
significantly fewer than both the Glu-stimulated value, a 52% reduction, and the control 
value, a 36% reduction.  Astrocytes treated with inhibitors alone had 74 ± 4 terminal 
points, also significantly fewer than the Glu-stimulated value, a 54% reduction, and the 
control value, a 39% reduction.  The number of branch terminal-points for SCN 
astrocytes treated with Glu and inhibitors was not significantly different from levels in 
astrocytes treated with inhibitors alone. 
 
Discussion 
 Light influences the distribution of GFAP-positive astrocytes in the SCN,57,58 and 
SCN astrocytes have been observed to be concentrated in the ventrolateral SCN.54  This 
area is highly innervated by retinal ganglion terminals from the eye.55,56  Astrocytes in the 
present studies did not have any preferential distribution, but observations were restricted 
to mid-section SCN.  DG and SCN astrocytes exhibit 24-h diurnal patterns of 
morphological oscillation based on 12 h light:12 h dark entrainment cycles (Fig. 2.2).  
These data implicate light as an influential mediator of astrocyte shape change, but they 
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do not establish whether light is necessary for diurnal rhythms or whether it is alone 
sufficient to produce them. 
Rodents display near-24-h “free-running” behavioral rhythms in constant 
darkness,147 and the circadian molecular clock also continues without light cues.148-150  If 
light is necessary for diurnal astrocyte remodeling, then constant darkness will abolish 
any rhythm.  In fact, astrocyte rhythms in GFAP morphology cease to exist in the DG or 
in the SCN in these conditions.  Light is fundamentally necessary for 24-h DG and SCN 
astrocyte morphology changes. 
Diurnal rhythms in DG astrocyte shape are in antiphase to those in the SCN.  This 
inverse relationship indicates that the astrocytes in these regions may respond differently 
to light, the cue that dictates the daily cycle of the animal facility.  In order to test this 
idea, animals were exposed to a light pulse at early night, the respective peak and trough 
time in GFAP branch complexity in the DG and SCN.  Astrocytes in the DG and SCN 
respond in opposite ways to light exposure, exhibiting decreased branching in the DG and 
increased branching in the SCN.  Not only do astrocytes in the SCN and DG possess 
quantifiably different GFAP morphologies at all times of day, reflecting possibly distinct 
functions, but the two populations respond differently to light.  These data provide a more 
physiological aspect to the growing body of evidence for regional astrocyte heterogeneity.  
 Light signaling through its chemical messenger Glu is capable of shifting the 
internal clock state and the rhythms in electrical activity.140,151,152  If direct Glu signaling 
is sufficient to drive GFAP oscillations, then Glu treatment of acute DG and SCN tissue 
slices will alone cause astrocyte restructuring.  Glu application at early night modifies 
SCN astrocyte morphology, but has no effect on DG morphology. 
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 Signaling of light from the retina to the SCN occurs initially through intrinsically 
photoreceptive retinal ganglion cells (ipRGCs).131  These neurons communicate to the 
SCN through pituitary adenylate cyclase-activating peptide (PACAP) and glutamate 
(Glu), which activate signaling cascades involving ionotropic and G protein-coupled 
receptors (GPCRs).132-135,140,153  How neurons in the SCN mediate signaling of light to 
SCN astrocytes is unclear.  Gap junction-coupled astrocytes in the hippocampus have 
been found to express Glu transporters but not receptors.23  SCN astrocytes express gap 
junctions,154-156 and if these astrocytes also lack Glu receptors, it is unlikely that light 
information is transmitted from neurons to astrocytes in the SCN via Glu.  This would 
raise the possibility that information is passed via PACAP through PACAP or vasoactive 
intestinal peptide (VIP) receptors, both expressed by a number of astrocytes populations 
in the brain.157-159  PACAP is known to modulate the glutamatergic SCN light 
response.133,153  Expression of PACAP receptors by astrocytes in several brain regions 
makes PACAP a strong candidate as the messenger of light to astrocytes in the SCN. 
 In the slice, the DG does not respond to Glu, the messenger of light from the 
retina to the SCN.  There is a discrepancy between the ability of a light pulse to stimulate 
DG astrocyte change in vivo and the inability of Glu to directly stimulate DG astrocyte 
change in an acute slice.  The proximate signal for DG astrocyte modification may be 
downstream of the glutamatergic SCN pathway.  The case for diffusible factors in 
mediating SCN communication is compelling,160-162 and a number of candidate molecules 
such as peptides await examination.  Substantial diffusion of small molecules in the brain 
may occur in relatively short periods of time,163 especially when aided by ventricular 
space, available to the SCN through the third ventricle.   
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  Glu receptor inhibitors NBQX and AP5 are together capable of blocking changes 
in the SCN caused by Glu, reducing branch terminal-point number below the usual 
diurnal low of early night.  Inhibitor treatment alone also reduces branch terminal-point 
number in SCN astrocytes below the control value, suggesting that glutamatergic tone 
contributes to maintaining the basal level of complexity.  NBQX specifically targets 
AMPA receptors, while AP5 targets NMDA receptors.  Future work involving treatment 
of SCN slices with Glu and each inhibitor separately will identify which receptor subtype 
is responsible for mediating astrocyte change. 
  Astrocyte structure rhythms depend on light signaling while circadian electrical 
activity does not.44,45,164  What, then, is the need for these astrocyte changes when 
circadian rhythms persist without them?  Blind humans who receive absolutely no photic 
information frequently present with sleep disorders.165-167  Dampened or even nonexistent 
astrocyte dynamics may contribute to these pathologies.  Astrocytes are indeed potent 
regulators of sleep homeostasis through release of adenosine,168,169 and misaligned or 
absent light signaling may disrupt this form of gliotransmission.  Light plays crucial roles 
in regulating daily organismal behavior as well as astrocyte morphology rhythms, and the 
















Fig. 3.1. Experimental design for constant dark, light pulse, and Glu treatment 
studies. (A) For constant dark experiments, animals are entrained to a 12 h light:12 h 
dark cycle for 10 d, then placed into constant dark for 3 d. Tissue is collected at circadian 
time (CT) 2 and CT 14, corresponding to 2 h and 14 h after lights-on in the original 
schedule. (B) For light pulse experiments, after 12 h light:12 h dark entrainment, a 15-
min light pulse is administered at Zeitgeber time (ZT) 14, and tissue is collected after 30 
min. (C) For Glu treatment experiments, animals are entrained to a 12 h light:12 h dark 
cycle, and brain slices are removed at ZT 7. Slices are then treated with Glu and/or Glu 






Fig. 3.2. In constant dark, DG and SCN astrocytes do not exhibit circadian patterns 
of GFAP morphology. (A) After 3 d entrainment in constant dark, GFAP in the DG at 
CT 2, 2 h after lights-on in the original lighting schedule, appears morphologically 
similar to GFAP in the DG at CT 14, 14 h after lights-on in the original lighting schedule. 
(B) DG branch terminal points/cell are not significantly different between CT 2 and CT 
14 (F1,6 = 0.034, p = 0.86, two-level mixed model ANOVA). (C) In constant dark, SCN 
astrocyte GFAP morphology at CT 2 appears similar to morphology at CT 14. (D) SCN 
branch terminal points/cell are not significantly different between CT 2 and CT 14 (F1,6 = 
0.033, p = .87, two-level mixed model ANOVA). Error bars represent SEM, n = 4 
brains/time point, 10-14 cells/DG sample, 10-19 cells/SCN sample. Scale bars = 50 µm 
top panels, 10 µm bottom panels. 
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Fig. 3.3. Light exposure in early night causes opposite alterations in astrocyte 
morphology in the DG and SCN.  (A) By 30 min after a 15-min light pulse at ZT 14, 
DG astrocytes are less branched than controls. (B) DG GFAP branch terminal-point 
number/cell is significantly lower after a light pulse than without light exposure (F1,6 = 
10.8, p = 0.017, * = p < 0.05, two-level mixed model ANOVA). (C) 30 min after a light 
pulse, SCN astrocytes are more branched than controls. (D) SCN branch terminal-point 
number/cell is significantly higher after a light pulse than in unpulsed controls (F1,6 = 
8.77, p = 0.025, * = p < 0.05, two-level mixed model ANOVA). Error bars represent 
SEM, n = 4 brains/condition, 13-21 cells/DG sample, 18-29 cells/SCN sample. Scale bars 
= 50 µm top panels, 10 µm bottom panels. 
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Fig. 3.4. GFAP levels in the DG and SCN do not change in response to light at early 
night. (A) After a light pulse at ZT 14, GFAP protein levels in the DG are not 
significantly different from controls that do not receive a light pulse (F1,6 = 0.029, p = 
0.87, Student’s t-test). (B) After a light pulse at ZT 14, GFAP protein levels in the SCN 
are not significantly different from controls (F1,6 = 2.29, p = 0.18, p = 0.18, Student’s t-









Fig. 3.5. Glu signaling directly alters GFAP morphology in the SCN, but not in the 
DG. (A) 30 min after a 10-min Glu treatment (1 µL, 10 µM) at CT 14, DG GFAP 
morphology is not visibly different from untreated controls. (B) After Glu treatment, DG 
branch terminal-points/cell do not significantly change relative to controls (p = 0.772, 
two-level mixed model ANOVA, n = 7 brains/control, 4 brains/Glu treatment, 10-15 
cells/DG sample). (C) After identical Glu treatment at CT 14, SCN GFAP morphology is 
more highly branched relative to controls. (D) SCN GFAP branch terminal-points/cell are 
significantly higher after Glu treatment compared to controls (p = 0.0089). After a 
treatment with Glu + Glu receptor inhibitors NBQX and AP5, SCN branch terminal-
points are significantly lower than controls (p = 0.0002) and Glu-treated (p < 0.0001) 
slices. Treatment with NBQX and AP5 alone also significantly lowers SCN branch 
terminal-points relative to control (p = 0.0002) and Glu-treated (p < 0.0001) slices. A 
significant difference was found between all treatment groups (F3,11 = 51.33, p < .0001, 
two-level mixed model ANOVA, ** = p < .005, *** = p < .0001, Tukey’s post-hoc 
comparison). Error bars represent SEM, n = 4 brains/condition, 3 brains for inhibitors 
alone, 10-23 cells/SCN sample. Scale bars = 50 µm top panels, 10 µm bottom panels. 
Treatments were completed with the assistance of Dr. Jennifer Mitchell. 
B. 









A classic astrocyte morphology phenomenon is the retraction of astrocyte 
processes in the supraoptic nucleus (SON) in response to dehydration.78,79  These 
stimulated changes facilitate increased direct contact and gap junction communication 
between SON neurons, enabling synchronized firing and upregulated peptide release.81  
The peptide hormone arginine vasopressin (AVP) increases water retention in the 
kidney,170 making AVP release from the SON particularly important during the 
dehydrated state.   
The suprachiasmatic nucleus (SCN), also located in the anterior hypothalamus, 
possesses numerous AVP-expressing neurons among other well-studied peptidergic 
neurons.171,172  AVP neurons in the SCN help convey time-of-day information to non-
SCN brain regions,173,174 and they also contribute to maintaining SCN neuronal 
synchrony.175  Astrocyte morphological responses due to dehydration have not been 
reported in the SCN or in other brain regions such as the hippocampus.  
In the SON, changes in morphological organization of glial fibrillary acidic 
protein (GFAP) also occur during dehydration,170 although these changes have not been 
observed beyond qualitative analysis.  Lactation induces neuronal membrane apposition 
and astrocyte retraction similarly to dehydration.80  Qualitative and semi-quantitative 
analysis of GFAP immunoreactivity in the SON shows that astrocytes have reduced 
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GFAP expression and branches during lactation.176  No study has quantitatively assessed 
GFAP morphology in the brain during dehydration, however.  
In the SON, whether dehydration-induced GFAP plasticity is mediated by 
fluctuations in protein level or by reorganization is unknown.  It is moreover unknown 
whether astrocyte morphologies in other brain regions such as the hippocampus and SCN 
respond to dehydration.  Correspondingly, if these changes do occur in the hippocampus 
or SCN, the mechanism of GFAP remodeling, through protein turnover or reorganization, 
is unclear.  The following studies employ confocal fluorescent imaging coupled with 3D 
reconstruction in the SON, dentate gyrus (DG) and SCN alongside Western blot analysis 
to answer these questions. 
The following studies address the specific aim: Examine GFAP morphology 
responses to dehydration in the hypothalamus and hippocampus.  The following sub-aims 
are evaluated: 1) Determine whether dehydration alters GFAP morphology in the SON, 
SCN and DG, and 2) Determine whether dehydration alters GFAP protein levels in the 
SON, SCN and DG.  
 
Materials and Methods 
Animal and Tissue Preparation 
Long Evans/BluGill male and female rats (University of Illinois) aged 10-20 
weeks were used for this study.  Animals evaluated with salt challenge were injected 
intraperitoneally at ZT 5 with either hypertonic (1.5 M NaCl) or isotonic (0.16 M NaCl) 
saline, 1.8 mL/100 g body weight.  Rats for immunohistochemistry were then perfused 
with 4% PFA at ZT 6.  For Western blot studies, brains removed from animals sacrificed 
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at the designated ZTs or after saline injection were sliced into 500 µm-thick coronal 
sections and punched with a 2 mm-diameter corer to remove DG and SCN tissue. 
Saline injections were completed by Dr. Jennifer Mitchell. 
Immunohistochemistry 
  Tissue sections were incubated with a primary monoclonal antibody against 
GFAP (Millipore) at a concentration of 1:10,000 for 1 h at room temperature and a 
secondary 488-nm wavelength goat anti-mouse antibody (Life Technologies) at 1:1,000 
for 1 h at room temperature.  Sections were also treated with DAPI to visualize nuclei 
(Life Technologies).  Each sample consisted of all hippocampal and SCN slices collected 
at each time point or condition.  All samples for each n were stained simultaneously.  
Microscopy and Imaging Analysis 
  A laser-equipped LSM-510 confocal microscope (Zeiss) was used to observe 
GFAP labeling.  Twenty images separated by 0.5 µm in thickness comprised a 3-
dimensional 10 µm-thick z-stack of the tissue.  Analysis of the SON focused above the 
ventral glial limitans (VGL) to identify individual GFAP-positive cells in the SON.  
Analysis of the hippocampus focused on the molecular layer of the DG in the most 
ventral area of the DG, ventral to the granular layer, to avoid GFAP-positive 
neuroprogenitors in the granular layer.  Analysis of the SCN focused on the mid-section 
SCN on either side of the bilaterally paired nuclei.  Images were processed using Imaris 





Western Blot Protein Quantification 
  Total protein (15 µg/sample) was resolved in 8% SDS-PAGE and transferred to 
polyvinyldifluoride (PVDF) membranes (Bio-Rad).  Membranes were probed with a 
1:10,000 dilution of mouse anti-GFAP antibody (Millipore) for 1 h at room temperature, 
a 1:10,000 dilution of goat anti-mouse antibody (Life Technologies) for 1 h at room 
temperature, and developed with SuperSignal Chemiluminescent Substrate (Pierce).  
After scanning, an anti-tubulin antibody (Cell Signaling) was applied at a 1:5,000 dilution 
for 1 h at room temperature, followed by a 1:10,000 dilution of goat anti-mouse antibody 
(Life Technologies).  GFAP levels were determined by the intensity of the GFAP band 
[molecular weight (MW) = 50 kD] over the intensity of the band labeled by anti-tubulin 
(MW = 55 kD) in the same lane, to control for possible unequal sample loading.   
  Western blots were completed with the assistance of James Chu. 
Statistical Analysis 
  For comparison of cell morphologies after hypertonic or isotonic saline injection, 
one-way two-level mixed model ANOVA was used.  For protein level analysis, Student’s 
t-test was used.  Mixed model ANOVA data were log-transformed to reduce skewness 
and to improve normality of the data, allowing parametric tests. 
  Statistical analysis was performed with the assistance of Dr. Justin Rhodes. 
 
Results 
GFAP morphology in the SON and in the SCN, but not in the DG, changes after 
hypertonic saline injection 
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 In a model of acute dehydration, animals were injected intraperitoneally with 
hypertonic saline and sacrificed after 1 h alongside control animals injected with isotonic 
saline.  In the SON, GFAP branch terminal-points are significantly fewer after injection 
with hypertonic saline, relative to isotonic controls (Figure 4.1A, B).  Parallel to the SON, 
GFAP branch-terminal points in the SCN are significantly fewer after hypertonic saline 
injection, relative to controls (Figure 4.2C, D).  Hypertonic saline injection does not, 
however, cause a significant change in GFAP branch terminal-point value in the DG, 
relative to controls (Figure 4.2A, B). 
GFAP levels do not change in the SON, SCN or DG after hypertonic saline injection 
 GFAP protein quantity in the SON after injection with hypertonic saline is not 
significantly different from GFAP protein quantity after injection with isotonic saline 
(Figure 4.3A).  In the DG (Figure 4.3B) and in the SCN (Figure 4.3C), GFAP levels also 
do not change after hypertonic saline injection, relative to controls. 
 
Discussion 
  Astrocyte retraction in the SON in response to dehydration is well studied on the 
levels of electron microscopy and qualitative GFAP imaging,78,79,82 but quantitative 
analysis of SON GFAP branch organization in this condition had not been performed.  In 
congruence with previous findings, SON GFAP terminal point-number sharply falls by 1 
h after treatment with hypertonic saline, a model of induced dehydration.  Interestingly, 
in previous studies, animals are either water-deprived for 4 to 24 h or given hypertonic 
saline to drink for at least 7 days in order to cause dehydration and astrocyte retraction.  
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The current findings observe astrocyte morphology changes by 1 h after hypertonic saline 
injection, underscoring the rapid responsiveness of these cells to osmotic conditions. 
  Early studies focused on the effects of dehydration on astrocytes in the SON and 
less extensively on the immediately dorsal nucleus circularis (NC),78 yet no study 
analyzed its effects on astrocytes of the nearby medial SCN or astrocytes outside of the 
hypothalamus completely, such as the hippocampus.  Astrocyte changes in the SCN 
during dehydration are in the same direction as those recorded in the other hypothalamic 
regions studied, the SON and the NC.  GFAP morphology in the hippocampal DG, 
however, remains unchanged in the dehydrated state.  The SON and SCN are highly 
peptidergic regions, and SON astrocyte retraction is posited to facilitate neuronal AVP 
release.  Branching changes in the SCN during dehydration may also influence the 
effectiveness of peptide signaling in the area, although whether these changes influence 
AVP neurons in particular is not yet known. 
  GFAP morphology in the DG that does not change following dehydration further 
highlights regional differences in the brain.  The lack of response in the DG also clarifies 
the functional specificity of astrocyte dehydration changes.  Hypertonic saline was 
administered intraperitoneally and thus, relatively equally to each area of the brain.  If 
astrocyte changes in response to dehydration are simply due to hyperosmotic cellular 
shrinkage, these effects should be observed across all brain regions.  GFAP restructuring 
is localized to the SON and SCN and not the DG, suggesting that these dynamics serve to 
promote the specific responses of the SON and SCN to dehydrating conditions. 
  The differing responses to dehydration between hypothalamic and hippocampal 
astrocytes are most likely due to dissimilar sensitivities to osmotic stress between these 
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populations.  The exact molecular profiles of these cells that allow for different responses 
remain unclear.  The protein assembly aquaporin-4/transient receptor potential vanilloid 4 
(AQP4/TRPV4) has been shown to be essential for regulatory volume decrease in 
primary cortical astrocytes during osmotic stress.177  It may be that this complex is more 
highly expressed or more active in SON and SCN astrocytes relative to DG astrocytes.  A 
variety of potassium and chloride channels also contribute to volume regulation 
following hypotonic conditions in cultured cortical and cerebellar astrocytes.178-180  While 
such channels have been shown to participate in volume reduction to balance hypotonic 
cell swelling, they may also promote morphology change in hypertonic conditions.  
Differing potassium and chloride conductances between hypothalamic and hippocampal 
astrocytes may contribute to discrepancies in sensitivity to hypertonic stress.          
  Finally, dehydration does not alter GFAP protein levels in the SON, SCN or DG.  
Similar to the results of the diurnal and light response analyses, GFAP morphology 
changes during dehydration are caused by reorganization of existing protein and not by 
protein turnover.  The consistent findings across experiments suggest a general 
mechanism of astrocyte GFAP shape remodeling.  It is possible that regardless of stressor 
or cue driving GFAP structural changes and regardless of the region, these changes are 










Fig. 4.1. Hypertonic saline injection reduces GFAP branch complexity in the 
supraoptic nucleus. (A) Astrocyte GFAP in the supraoptic nucleus (SON) is less 
branched 1 h after hypertonic saline injections compared to isotonic controls. (B) Branch 
terminal-points/cell in the SON are significantly fewer after hypertonic saline compared 
to isotonic controls (F1,6 = 338.2, *** = p < .0001, two-level mixed model ANOVA). 
Error bars represent SEM, n = 4 brains/condition, 10-24 cells/SON sample. Scale bars = 
50 µm top panels, 10 µm bottom panels.  Saline injections were performed by Dr. 
Jennifer Mitchell. 
 










Fig. 4.2. Hypertonic saline treatment changes GFAP branch complexity in the SCN, 
but not in the DG. (A) GFAP organization in the DG 1 h after hypertonic saline 
treatment appears similar compared to isotonic controls. (B) DG branch terminal-
points/cell do not change after hypertonic treatment compared to controls (F1,6 = 0.30, p = 
0.60, two-level mixed model ANOVA). (C) GFAP in SCN astrocytes appears less 
branched after hypertonic treatment relative to controls. (D) SCN branch terminal-
points/cell are significantly fewer after hypertonic treatment compared to controls (F1,6 = 
8.46, p = 0.027, two-level mixed model ANOVA). Error bars represent SEM, n = 4 
brains/condition, 11-20 cells/DG sample, 10-15 cells/SCN sample. Scale bars = 50 µm 




















Fig. 4.3. Hypertonic saline treatment does not alter GFAP levels in the SON, DG or 
SCN. (A) 1 h after hypertonic saline injection, SON GFAP content is not significantly 
different from isotonic controls (F1,6 = 0.79, p = 0.41, Student’s t-test). (B) DG GFAP 
levels after hypertonic treatment are not different from controls (F1,6 = 2.21, p = 0.19, 
Student’s t-test). (C) SCN GFAP levels after hypertonic treatment are not different from 
controls (F1,6 = 0.16, p = 0.71, Student’s t-test). Error bars represent SEM, n = 4 






CHAPTER 5.  DIURNAL AND STIMULATED ASTROCYTE MORPHOLOGY 
DYNAMICS AND THEIR FUNCTIONAL IMPLICATIONS 
 
  Whereas astrocytes exhibit heterogeneities in ion channels, enzymes, and 
chemical transmitters, few differential roles in actively modulating brain function have 
been identified.15-21,181  Astrocytes change with remarkable structural plasticity in 
response to physiological need.79,88,93,182  However, evidence for differences in basal 
astrocyte structure between brain regions and over the day-night cycle has been 
fragmentary.  
  In evaluating these basal characteristics, the described studies found that astrocyte 
morphologies in regions of the hippocampus and hypothalamus change diurnally and in 
antiphase, with significantly different patterns of oscillations in glial fibrillary acidic 
protein (GFAP) cytoarchitecture.  While undergoing these diurnal oscillations in 
morphology, astrocytes maintain their regional morphological identities.  
Suprachiasmatic nucleus (SCN) astrocytes are significantly more highly branched than in 
the hippocampal dentate gyrus (DG) at all times of day.  Properties of astrocytes such as 
gene expression reflect the specialized functions of the brain regions they inhabit.15-21  
Region-specific morphologies likely contribute to the region-specific tasks of astrocytes 
in their local environments, but these have yet to be elucidated.  
  Because the core molecular clock persists in the absence of light-dark cues,148-150 
it is conceivable that astrocytes also maintain circadian structural rhythms without light.  
Both constant light and constant darkness, however, alter GFAP distribution in the 
SCN.57-59  This suggests that signals from the eye are primary regulators of diurnal 
 59	  
changes in astrocyte morphology.  Animals in constant dark lose GFAP structural 
rhythms, demonstrating that the molecular clock alone is not enough to support these 
changes.  Light is necessary for the maintenance of astrocyte morphology rhythms in 
both the DG and SCN.   
  Differences in astrocyte light responsiveness between brain regions have not been 
previously explored.  Astrocyte structure responds to light exposure in opposite ways in 
the DG and SCN, such that light rapidly diminishes DG branch terminal-points, but 
enhances structural complexity of SCN astrocytes.  These data contribute a more 
dynamic perspective to earlier work on regional differences in astrocyte morphology.  
Inversion of rhythms between the DG and SCN resembles the opposing rhythms in the 
excitability of neurons and expression of the clock gene, Period 2, in these regions.124,183  
  To assess the sufficiency of light and specifically the glutamate (Glu) signaling 
pathway in astrocyte morphology rhythms, acute hippocampal and SCN brain slices were 
treated with Glu at early night.  Glu stimulation does not change GFAP morphology 
acutely in the DG, but Glu alone is capable of rapidly increasing SCN GFAP branch 
terminal-points, a change in structure to a more daytime-like state.  These data indicate 
that Glu and light directly modulate astrocyte structure in the SCN.  A separate molecule, 
possibly downstream of the SCN, may promote astrocyte remodeling in the DG.  Light 
signaling is sufficient to induce cytoskeletal restructuring in the intact SCN slice culture, 
although it is unclear whether the intact molecular clock in this system is necessary for 
the observed response.  Treatment of slices from transgenic animals lacking core 
components of the molecular clock may answer this question.  
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  How distinct morphologies influence astrocyte function in different brain regions 
and how morphological rhythms might relate to glial physiology remain to be determined.  
Neuronal excitability in the rodent hippocampus exhibits a diurnal rhythm with a 
nighttime peak,184 and in the DG, long-term potentiation (LTP) is enhanced at night 
relative to the day.185,186  LTP depends on D-serine released by local astrocytes,38 and 
increased branching of DG astrocytes at night may facilitate the localized presence of D-
serine for neurons participating in LTP.  The importance of day-night astrocyte rhythms 
to the biology of learning and memory remains largely undetermined, although astrocyte 
morphology likely contributes to these hippocampal processes in significant ways.   
  Light signaling is necessary for appropriate sleep patterns,165-167 and astrocytes 
participate in sleep homeostasis through the release of adenosine.168,169  Light-dependent 
astrocyte remodeling may promote this critical function.  Furthermore, extracellular fluid 
space in the cortex expands during sleep, allowing clearance of metabolites from the 
brain.187  Although there is no evidence for these sleep-related changes in the SCN, 
nighttime astrocyte remodeling may contribute to this state.  Neuronal activity coupling 
between SCN cells is thought to be mediated by diffusible factors such as peptides.188,189  
In effect, diurnal oscillations in branching of SCN astrocyte processes may modulate the 
tortuosity of the tissue and thereby the diffusion of coupling signals as well as clearance 
of interstitial solutes.190  
  Future directions for these studies will focus on expanding the parameters of 
astrocyte morphology to encompass values such as cell surface area.  The GFAP-GFP 
mouse allows measurement of approximate cell volume, but very fine structures that 
largely contribute to astrocyte surface area may not be defined by the GFP molecule.  
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Dye-filling of cells through the use of patch pipettes may enable visualization of these 
structures, and genetically encoded calcium indicators (GECIs) also provide high 
resolution imaging of complete cell morphology. 
  Additional future directions include determining whether diurnal oscillations in 
astrocyte morphology occur elsewhere in the brain, and if so, if they occur in the same 
phasing as those described in the DG or SCN.  Diurnal electrical activity rhythms outside 
the SCN are generally found to be in antiphase to those in the SCN.191  Morphology 
rhythms in the DG and SCN are inverted, and while it is predicted that putative rhythms 
in other regions also oppose SCN rhythms, this has not been determined.  The DG and 
the SCN are ideal locations to begin diurnal astrocyte morphology studies, yet the rest of 
the brain remains uninvestigated. 
  The most enigmatic and possibly most challenging aspect of future studies is 
probing the functional consequences of daily astrocyte morphology dynamics.  One of 
the largest obstacles to this endeavor is the lack of knowledge concerning the 
mechanisms of astrocyte remodeling, especially GFAP reorganization.  While actin 
polymerization and depolymerization pathways have been described to the extent that 
assembly and disassembly can be specifically promoted through chemical application,192-
195 the same cannot be said for GFAP.  Identification of such chemical pathways and their 
manipulations for GFAP would better enable the study of the functional importance of its 
daily structural changes.   
  These findings raise questions as to how changes in astrocyte morphology and 
spatial relationships serve astrocyte and neuronal function in different brain regions.  
Identification of their physiological roles notwithstanding, heterogeneities in astrocyte 
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structural dynamics and light-entrained oscillations no doubt contribute broadly and 
importantly to the biology of the nervous system.  Thus, astrocyte rhythm dysfunctions 
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